Sr. Petersen et al., ADJUVANT RECOMBINANT HUMAN GROWTH-HORMONE STIMULATES INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 SECRETION IN CRITICALLY ILL TRAUMA PATIENTS, The journal of trauma, injury, infection, and critical care, 39(2), 1995, pp. 295-302
The early catabolic phase of severe injury is associated with acute gr
owth hormone (GH), insulin-like growth factor-1 (IGF-1), and insulin-l
ike growth factor binding protein-3 (IGFBP-3) deficiency. The metaboli
c half-life of circulating IGF-1 is prolonged by its binding to IGFBP-
3. The role of this binding protein in nutritionally repleted multiple
-injury patients has not been previously evaluated. We have measured p
lasma levels of these polypeptides and nitrogen (N) balance in 18 adul
t (15 males/3 females; mean age, 45 years), severely injured, hyper-me
tabolic, and highly catabolic trauma patients within 48 to 60 hours af
ter injury, when they were receiving maintenance fluids without calori
es or N and during 6 days of total parenteral nutrition (TPN). Before
instituting TPN, the patients were randomized to receive (group H, n =
9) or not to receive (group C, 9) daily recombinant human growth horm
one (rhGH), 0.15 mg/kg IM. Adjuvant rhGH significantly increases plasm
a levels of GH, IGF-1, IGFBP-3, and insulin. In addition, it shows bet
ter improvement in N balance. The bioavailability of IGF-1 is increase
d, as indicated by the decrease in IGFBP-3:IGF-1 ratio. A significant
correlation between IGF-1 and IGFBP-3 levels is present in the trauma
patients who received TPN and rhGH. A GH/IGF-1/IGFBP-3 axis that close
ly regulates the metabolic status of the patient is established in tra
uma.